Dear Dr Jones,                                 [See previous correspondence]

I understand there have been letters from Sarah Wark from your Pharmacovigilance Group recently to SSRI companies saying that the CSM has recently reviewed the issue of SSRIs and Suicidal Behaviour. The conclusion apparently was that the available study data did not support a causal association between SSRIs and Suicidal Behaviour. I would greatly appreciate if you could let me know exactly what study data were considered. I would also appreciate any reports that were prepared for this meeting.

I also understand that the letter to the different companies refers to a recent SSRI Core Safety Exercise. Again on this issue I would appreciate any papers or minutes or other relative material relating to this exercise. As in my previous letter please consider this a formal request for information under the code of practice on access to Government information.

Yours sincerely

David Healy MD FRCPsych

Director, North Wales Department of Psychological Medicine

The MCA acknowledged this letter on 14 September: " … a response will be forwarded to you as soon as the necessary information has been gathered."

CLICK HERE TO READ ON

	Contents page
	What's New?